Our clinic just turned on a “draft translation” feature that auto-renders after-visit summaries into Spanish and Vietnamese and sends them to us for review within 24 hours. It’s quicker, but I’m watching for precision on terms like “contraindicated” and making sure dosing and side effects are unambiguous — how are your teams handling review turnaround and consent language with similar rollouts?
Same here — the 24-hour window is tight, so we triage med-heavy summaries first and route them to a bilingual pharmacist; anything with “contraindicated” or taper schedules gets a second pass… For consent, we locked approved Spanish/Vietnamese snippets in the portal and run a quick diff to catch unit switches (mg vs mcg) and decimal shifts — , that’s bitten us before. If you’re on Epic, SmartPhrases plus a tiny number/units check script shaved about 30% off turnaround; do you gate release until two sets of eyes are on dosing?
We added a quick QA pass that auto-flags numbers/units and enforces a glossary, so “contraindicated” always lands as “contraindicado” and not a softer synonym before the human review. For consent, we use a locked bilingual paragraph pre-approved by legal and link to the full plain-language version in the portal (borrowed from AHRQ’s toolkit: https://www.ahrq.gov/health-literacy/improve/precautions/toolkit.html). It’s like bowling with bumpers — editors focus on the gutters while the routine stuff stays in lane.
We gate release with the 24-hour window: low-risk drafts go out, but anything with a taper or ‘contraindicated’ stays blocked until a second reviewer signs off. Biggest win was a no-translate list for brand names and labs, and we auto-expand BID/PRN into plain Spanish/Vietnamese so dosing reads clean. For consent, a one-tap banner on first view that says ‘machine-assisted draft — clinician review pending’ has worked, though it adds a tiny friction.